Rheumatology - European Medical Journal

Continue

Rheumatology

Filter
9 Mins
20 Nov 2017

Time To Control Gout and Make It Crystal Clear

Prof Fernando Perez-Ruiz opened the symposium, which focussed on the current unmet need in controlling gout and associated comorbidities with current…
7 Mins
26 Oct 2017

The International Osteoporosis Foundation Continues Campaign to Raise Awareness of Osteoporosis

To mark this year’s World Osteoporosis Day (WOD) on the 20th October 2017, the European Medical Journal spoke to the International Osteoporosis…
3 Mins
9 Aug 2017

Spasmodic Dysphonia: What About It?

Spasmodic dysphonia (SD): what about it? That is the million-dollar question.
11 Mins
1 Aug 2017

Biosimilars and Switching: What is your Perspective?

The licensing of biosimilars heralds the start of a new era for physicians treating immune and inflammatory diseases.
9 Mins
1 Aug 2017

Switching Patients from Originator to Biosimilar Medications in Rheumatoid Arthritis: Limiting The ‘Nocebo’ Effect

Biosimilars have been available in Europe since 2006, and biosimilars of monoclonal antibodies since 2013, and are now a widespread clinical reality.
9 Mins
1 Aug 2017

The Patient’s Perspective on Psoriatic Arthritis: What more can Rheumatologists do to Optimise Disease Management?

The symposium at the EULAR 2017 congress aimed to provide insights into the burden of psoriatic arthritis on patients’ daily lives, including the…
9 Mins
1 Aug 2017

Editor’s Pick: Why do Diseases Start One Sided? Clues From HLA-B27 Acute Anterior Uveitis

Uveitis is an inflammatory disease with significant disease burden, as it causes ≤10% of legal blindness in the USA.
8 Mins
1 Aug 2017

Osmolytes as Mediators of the Muscle Tissue’s Responses to Inflammation: Emerging Regulators of Myositis with Therapeutic Potential

In this review, the role of the organic osmolytes taurine, betaine, myo-inositol, and sorbitol in skeletal muscles in general, and in myositis in…